Customer Stories
Procurement workflows that worked.
Anonymized accounts drawn from real PeptideXpo engagements, every name, geography, and number removed or rounded, but the procurement structure, timeline, and outcome preserved. Each story covers a different buyer type and a different commercial scenario.
US compounding pharmacy switched suppliers mid-cycle and cleared a backlog of GLP-1 prescriptions in 5 weeks
A US Northeast 503A compounding pharmacy was losing patient throughput when its previous bulk-active supplier missed three consecutive lead-time commitments. Switching to PeptideXpo against a 6-month forecast cleared the backlog and stabilised the dispensing schedule.
Stockouts in 12 months post-switch
0
Backlog clearance time
~5 weeks
First reply from regulatory team
Within 12-hour SLA
Forecast horizon
6 months
Read the story
EU med-spa group launched a private-label GHK-Cu serum line in 11 weeks, end-to-end
A multi-location EU aesthetic-medicine group wanted to launch a retail-friendly anti-aging serum under its existing clinic brand. The OEM workflow took it from signed brief to first commercial shipment in 11 weeks.
Signed brief → first shipment
11 weeks
CPNP notification round-trips
1 (first-review approval)
Stability protocol
Accelerated + real-time
Locations launched
8 clinics · 2 countries
Read the story
Academic CNS research lab qualified a custom peptide for in vivo studies in 7 weeks
A US-based academic neuroscience lab studying a novel cognitive-pathway peptide needed bulk-scale material qualified for rodent intranasal administration. The custom-synthesis workflow ran from sequence brief to validated commercial-scale batch in 7 weeks.
Sequence brief → commercial batch
7 weeks
Pilot batch validation time
4 business days
Measured HPLC purity
≥99.2%
Endotoxin spec
<0.1 EU/mg
Read the story
Southeast Asian distributor built a region-exclusive GLP-1 inventory line in 4 months
A Southeast Asian aesthetic-medicine distributor wanted to expand from a generalist catalog into a region-exclusive peptide-active distribution channel. Partnership economics and forecast-based inventory took it from initial inquiry to a structured commercial relationship in 4 months.
Inquiry → structured partnership
4 months
SEA markets covered
4
Effective lead time on releases
Next-available-shipment
Forecast horizon
12 months
Read the story
Biotech R&D group developed a non-standard modified peptide from concept to gram-scale in 9 weeks
A pre-clinical biotech R&D group needed a custom-modified peptide combining a non-natural amino acid, intramolecular disulfide bridging, and N-terminal acetylation. The development workflow ran from concept brief to validated gram-scale material in 9 weeks.
Concept → pilot batch delivery
5 weeks
Concept → commercial-scale
9 weeks
Measured HPLC purity
≥99.1%
Modifications handled
3 concurrent (Dmt + S-S + Ac)
Read the story
Let's talk peptides.
First response under 12 hours · Catalog · Sample COA · MOQ · Lead time. Our regulatory and sales teams review every inquiry before pricing.